Acusensus Ltd (ACE) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): 361.88K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.16
• Revenue Growth: 19.60%
• EPS Growth: -59.17%
• Country: AU
• Employees: 164
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Infrastructure
• EPS (TTM): >-0.01
• Shares Outstanding: 141,613,600
• 10 Day Avg. Volume: 549,798
• 30 Day Avg. Volume: 361,885
• PEG Ratio: -0.78
• Price to Book (P/B): 2.72
• Price to Sales (P/S): 2.14
• P/FCF Ratio: -17.57
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$1.84
• Price Target Upside: 12.20% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 3
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 49 Neutral
• Price Target: AU$1.50 ▼(-8.54% Downside)

Acusensus Ltd's stock score is primarily impacted by its financial performance challenges, particularly in profitability and cash flow management. Technical analysis shows some positive momentum, but valuation concerns due to a negative P/E ratio weigh heavily on the overall score.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong demand for Acusensus's technology solutions, enhancing its market position and potential for future expansion.

Low Leverage

Low leverage provides financial stability and flexibility, allowing Acusensus to invest in growth opportunities without significant debt burden.

Market Position

Specialization in AI-driven traffic solutions positions Acusensus as a leader in a niche market, potentially benefiting from smart city initiatives and regulatory support.

Negative Factors

Profitability Issues

Ongoing profitability challenges may hinder Acusensus's ability to reinvest in its business, affecting long-term growth and shareholder returns.

Cash Flow Management

Negative free cash flow indicates potential liquidity issues, limiting Acusensus's capacity to fund operations and strategic initiatives without external financing.

Operational Efficiency

Inefficiencies in operations can lead to higher costs and reduced margins, impacting Acusensus's competitive edge and profitability over time.

Acusensus Ltd Business Overview & Revenue Model

Company Description

Acusensus Limited, an intelligent traffic solutions (ITS) technology company, designs, develops, and commercializes technology focuses on the detection of distracted drivers in Australia. It offers s Acusensus Heads Up solution used to detect and capture prosecutable evidence of drivers illegally using mobile phones, whilst driving; Acusensus Heads-Up (Real Time Enforcement), a system for real-time enforcement of distracted driving and other offences; and Harmony enforcement camera system for use in developing economies. The company was incorporated in 2018 and is headquartered in Melbourne, Australia.

How the Company Makes Money

Acusensus Ltd generates revenue primarily through the sale of its technology solutions and services, which include software licensing, hardware sales, and ongoing support and maintenance contracts. The company also earns income from data analytics services, providing valuable insights to clients about traffic patterns and compliance rates. Key revenue streams come from government contracts for traffic monitoring and safety improvement projects, partnerships with municipalities for smart city initiatives, and collaborations with private enterprises seeking to enhance their fleet management capabilities. Additionally, ACE may benefit from grants or funding related to road safety advancements and smart infrastructure development.

Acusensus Ltd Financial Statement Overview

Summary

Acusensus Ltd is experiencing revenue growth but struggles with profitability and cash flow management. The balance sheet is stable with low leverage, but operational efficiency needs improvement.

Income Statement

Acusensus Ltd has shown a consistent revenue growth rate, with a 10.57% increase in the latest year. However, the company is struggling with profitability, as indicated by negative net profit margins and EBIT margins. The gross profit margin has improved over time but remains moderate. The negative EBIT and net income suggest challenges in managing operational costs effectively.

Balance Sheet

The company's balance sheet shows a relatively low debt-to-equity ratio, indicating conservative leverage. However, the return on equity is negative, reflecting ongoing profitability issues. The equity ratio is healthy, suggesting a solid capital structure, but the company needs to improve its return on equity to enhance shareholder value.

Cash Flow

The cash flow statement highlights significant challenges, with negative free cash flow and a declining free cash flow growth rate. The operating cash flow to net income ratio is positive, indicating some ability to generate cash from operations, but the negative free cash flow to net income ratio underscores the need for better cash management.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	59.35M	59.35M	49.63M	42.00M	28.65M	6.27M
Gross Profit	26.57M	26.57M	22.58M	4.61M	3.21M	-1.18M
EBITDA	-366.00K	3.89M	5.33M	5.35M	4.38M	-2.97M
Net Income	-2.62M	-2.62M	-1.52M	55.37K	1.43M	-3.65M
Balance Sheet
Total Assets	73.53M	73.53M	48.69M	48.46M	26.16M	19.57M
Cash, Cash Equivalents and Short-Term Investments	21.45M	21.45M	19.34M	24.80M	8.61M	12.33M
Total Debt	7.93M	7.93M	2.19M	2.19M	2.33M	977.62K
Total Liabilities	26.73M	26.73M	12.77M	12.54M	9.40M	4.50M
Stockholders Equity	46.79M	46.79M	35.92M	35.92M	16.76M	15.07M
Cash Flow
Free Cash Flow	-4.99M	-7.23M	-3.94M	-1.12M	-2.28M	-3.85M
Operating Cash Flow	8.27M	8.27M	3.58M	4.26M	4.97M	-1.00M
Investing Cash Flow	-13.71M	-13.71M	-7.52M	-17.37M	-7.24M	-3.17M
Financing Cash Flow	9.25M	9.25M	-1.47M	17.34M	-1.44M	15.38M

Acusensus Ltd Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1.64
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ACE, the sentiment is Neutral. The current price of 1.64 is below the 20-day moving average (MA) of 1.74, below the 50-day MA of 1.74, and above the 200-day MA of 1.18, indicating a neutral trend. The MACD of -0.03 indicates Positive momentum. The RSI at 40.00 is Neutral, neither overbought nor oversold. The STOCH value of 25.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:ACE.

Acusensus Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
ACE	49 Neutral	―	-108.90	-6.34%	―	19.60%	-59.17%
SEN	48 Neutral	AU$45.59M	-1.59	-64.51%	5.01%	-38.38%	-275.50%
WHK	46 Neutral	AU$9.61M	-2.63	―	―	13.07%	68.60%
FCT	42 Neutral	AU$22.83M	-1.46	-54.62%	―	-22.47%	39.26%
KNO	42 Neutral	AU$6.92M	-4.44	-23.31%	―	2.15%	-900.00%
NET	36 Underperform	AU$11.64M	-3.13	―	―	-20.82%	17.27%

Acusensus Ltd Corporate Events

Acusensus Ltd Announces Quotation of New Securities on ASX

Acusensus Ltd has announced the quotation of 377,352 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code ACE, effective December 3, 2025. This move is part of an employee incentive scheme and reflects the company’s ongoing efforts to enhance its market presence and operational capabilities.

Acusensus Ltd to Quote New Securities on ASX

Acusensus Ltd has announced the issuance of 197,302 ordinary fully paid securities, which will be quoted on the Australian Securities Exchange (ASX) under the code ACE. This move is part of the company’s strategy to enhance its market presence and operational capabilities, potentially impacting its industry positioning by increasing its capital base and shareholder value.

Acusensus Announces Change in Director’s Interest

Acusensus Limited has announced a change in the director’s interest, specifically involving Alexander Jannink, who is a director, shareholder, and beneficiary of Jannink & Associates Pty Ltd. This change in interest involves unquoted performance rights and reflects the company’s ongoing governance and compliance with ASX listing rules. Such changes can impact the company’s operational transparency and investor relations, maintaining stakeholder confidence in its governance practices.

Acusensus Ltd Issues Performance Rights to Boost Employee Engagement

Acusensus Ltd has announced the issuance of 225,275 performance rights as part of an employee incentive scheme. These unquoted securities are not intended to be listed on the ASX, reflecting the company’s strategy to enhance employee engagement and retention through equity-based incentives. This move is likely to strengthen Acusensus’s operational framework by aligning employee interests with company performance, potentially impacting its market positioning positively.

Acusensus Reports Successful 2025 AGM Outcomes

Acusensus Limited announced the successful outcomes of its 2025 Annual General Meeting, with all resolutions passed. This development reflects positively on the company’s governance and strategic direction, potentially strengthening its position in the road safety technology industry and reassuring stakeholders of its commitment to innovation and safety.

Acusensus Expands Speed Camera Contract in Queensland

Acusensus Limited has announced an expansion of its contract with the Queensland Department of Transport and Main Roads, doubling the number of trailer-based speed enforcement units. This expansion, valued at approximately $16.6 million, will see new units deployed from November 2025 through 2026, each for an initial five-year term. The program has already demonstrated significant success, with a 92% reduction in excessive speeding detected in the first seven months, highlighting its impact on road safety and driver behavior.

Acusensus to Present AI Road Safety Solutions at Morgans Conference

Acusensus Limited announced that its Co-Founder and Managing Director, Alexander Jannink, will present at the Morgans Conference in Noosa, Australia. The presentation highlights Acusensus’ commitment to leveraging AI technology to enhance road safety by providing digital evidence for law enforcement. This announcement underscores the company’s ongoing efforts to strengthen its industry position and its dedication to improving road safety through innovative solutions.

Acusensus Announces 2025 Annual General Meeting Details

Acusensus Limited has issued its 2025 Notice of Annual General Meeting, scheduled for November 19, 2025, in Melbourne. The notice provides details on the meeting’s agenda and shareholder participation. This announcement signifies Acusensus’s ongoing commitment to transparency and shareholder engagement, potentially impacting its operational strategies and stakeholder relations.

Acusensus Ltd to Quote 745,000 New Securities on ASX

Acusensus Ltd has announced the application for the quotation of 745,000 ordinary fully paid securities on the Australian Securities Exchange (ASX), with the issue date set for October 17, 2025. This move is part of the company’s strategic efforts to enhance its market presence and operational capabilities, potentially impacting its industry positioning and offering new opportunities for stakeholders.

Acusensus Secures $8.7 Million Contract for WA Road Safety Camera Program

Acusensus Limited has secured a new $8.7 million contract with the Western Australian government to supply multi-function fixed site enforcement camera programs. This five-year agreement, which follows a successful trial, will enhance road safety by deploying cameras on major freeways to detect various traffic offenses. This contract, alongside a previous trailer-based enforcement agreement, strengthens Acusensus’ position in Western Australia as a key provider of road safety technology.

Acusensus Ltd Issues Performance Rights to Boost Employee Incentives

Acusensus Ltd has announced the issuance of 2,611,776 performance rights as part of an employee incentive scheme. These securities are unquoted and are not intended to be listed on the ASX, reflecting the company’s strategy to motivate and retain key personnel, potentially enhancing its operational capabilities and market position.